Stratec SE

XETRA SBS.DE

Stratec SE Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 39.12 M

Stratec SE Net Cash Used Provided By Financing Activities is USD 39.12 M for the year ending December 31, 2023, a 359.21% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Stratec SE Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -15.09 M, a 61.38% change year over year.
  • Stratec SE Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -39.08 M, a -712.49% change year over year.
  • Stratec SE Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 6.38 M, a 4.24% change year over year.
  • Stratec SE Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 6.12 M, a 676.91% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
XETRA: SBS.DE

Stratec SE

CEO Mr. Marcus Wolfinger
IPO Date June 16, 2000
Location Germany
Headquarters Gewerbestrasse 37
Employees 1,462
Sector Health Care
Industries
Description

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Similar companies

DRW3.DE

Drägerwerk AG & Co. KGaA

USD 50.29

3.14%

COP.DE

CompuGroup Medical SE & Co. KGaA

USD 22.41

0.70%

EUZ.DE

Eckert & Ziegler Strahlen- und Medizintechnik AG

USD 48.95

1.72%

PFV.DE

Pfeiffer Vacuum Technology AG

USD 158.71

0.74%

COK.DE

Cancom SE

USD 23.50

-0.70%

StockViz Staff

January 15, 2025

Any question? Send us an email